The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Tumor Necrosis Factor α Inhibits Glutamate Uptake by Primary Human Astrocytes
Open accessAbstract
Human immunodeficiency virus (HIV) infection is commonly associated with neurological disease that occurs in the apparent absence of extensive infection of brain cells by HIV, suggesting that indirect mechanisms account for neuropathogenesis in the CNS, perhaps including changes in the normal neuroprotective functions of astrocytes. To test this hypothesis, we examined the effect of the pro-inflammatory cytokine, tumor necrosis factor alpha (TNFalpha), produced by HIV-1-infected macrophages and microglia, on glutamate transport by primary human fetal astrocytes (PHFAs). A dose-dependent inhibition of high affinity glutamate uptake sites was observed 12-24 h after addition of exogenous recombinant human TNFalpha to PHFAs. This effect was specific since it was blocked by a neutralizing monoclonal antibody directed against TNFalpha. Furthermore, the inhibitory effect was reproduced by a monoclonal antibody that is an agonist at the 55-kDa TNF receptor. These results suggest that the neurotoxic effects of TNFalpha may be due in part to its ability to inhibit glutamate uptake by astrocytes, which in turn may result in excitotoxic concentrations of glutamate in synapses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Self-citationElliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis
Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471
Self-citationAn excitatory amino-acid transporter with properties of a ligand-gated chloride channel
Fairman, W. A., Vandenberg, R. J., Arriza, J. L., Kavanaught, M. P., & Amara, S. G. (1995) · Nature · doi:10.1038/375599a0 · Cited by 1,131
Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex
Arriza, J., Fairman, W., Wadiche, J., Murdoch, G., Kavanaugh, M., & Amara, S. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05559.1994 · Cited by 993
Brockhaus, M., Schoenfeld, H. J., Schlaeger, E. J., Hunziker, W., Lesslauer, W., & Loetscher, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3127 · Cited by 661
Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action
Benveniste, E. N. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.263.1.c1 · Cited by 607
Genis, P., Jett, M., Bernton, E. W., Boyle, T., Gelbard, H. A., Dzenko, K., Keane, R. W., Resnick, L., Mizrachi, Y., & Volsky, D. J. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1703 · Cited by 531
Self-citation
Cited by
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Pathways to neuronal injury and apoptosis in HIV-associated dementia
Kaul, M., Garden, G. A., & Lipton, S. A. (2001) · Nature · doi:10.1038/35073667 · Cited by 1,210
Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., et al. (2001) · Nature Neuroscience · doi:10.1038/89490 · Cited by 1,102
Minagar, A., Shapshak, P., Fujimura, R., Ownby, R., Heyes, M., & Eisdorfer, C. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00207-1 · Cited by 537
Werner, P., Pitt, D., & Raine, C. S. (2001) · Annals of Neurology · doi:10.1002/ana.1077 · Cited by 486
Trotti, D., Danbolt, N. C., & Volterra, A. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01230-9 · Cited by 468
Cytokines and brain excitability
Galic, M. A., Riazi, K., & Pittman, Q. J. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.12.002 · Cited by 446
Zou, J. Y., & Crews, F. T. (2005) · Brain Research · doi:10.1016/j.brainres.2004.11.014 · Cited by 410
High Affinity Glutamate Transporters: Regulation of Expression and Activity
Gegelashvili, G., & Schousboe, A. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.1.6 · Cited by 397
Neuroinflammation and regulation of glial glutamate uptake in neurological disorders
Tilleux, S., & Hermans, E. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21325 · Cited by 381
Transporters for L‐glutamate: An update on their molecular pharmacology and pathological involvement
Beart, P. M., & O'Shea, R. D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706949 · Cited by 377
Cytokine Effects on Glutamate Uptake by Human Astrocytes
Hu, S., Sheng, W. S., Ehrlich, L. C., Peterson, P. K., & Chao, C. C. (2000) · Neuroimmunomodulation · doi:10.1159/000026433 · Cited by 376
The link between excitotoxic oligodendroglial death and demyelinating diseases
Matute, C., Alberdi, E., Domercq, M., Pérez-Cerdá, F., Pérez-Samartı́n, A., & Sánchez-Gómez, M. V. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01746-x · Cited by 348
Sweitzer, S., Martin, D., & DeLeo, J. A. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00574-1 · Cited by 344
Su, Z.-Z., Kang, D.-C., Chen, Y., Pekarskaya, O., Chao, W., Volsky, D. J., & Fisher, P. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205445 · Cited by 320
Glial neuronal signaling in the central nervous system
Hansson, E., & Rönnbäck, L. (2003) · The FASEB Journal · doi:10.1096/fj.02-0429rev · Cited by 315
Aronica, E., Gorter, J. A., Ijlst‐Keizers, H., Rozemuller, A. J., Yankaya, B., Leenstra, S., & Troost, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02657.x · Cited by 305
MCP‐1 (CCL2) protects human neurons and astrocytes from NMDA or HIV‐tat‐induced apoptosis
Eugenin, E. A., D'Aversa, T. G., Lopez, L., Calderon, T. M., & Berman, J. W. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01775.x · Cited by 288
Boven, L. A., Gomes, L., Hery, C., Gray, F., Verhoef, J., Portegies, P., Tardieu, M., & Nottet, H. S. L. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4319 · Cited by 280
Emdad, L., Sarkar, D., Su, Z.-Z., Randolph, A., Boukerche, H., Valerie, K., & Fisher, P. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3029 · Cited by 276
Sweitzer, S. M., Schubert, P., & DeLeo, J. A. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29652-x · Cited by 266
Role of the pro‐inflammatory cytokines TNF‐α and IL‐1β in HIV‐associated dementia
Brabers, N. A. C. H., & Nottet, H. S. L. M. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01657.x · Cited by 265
Interleukin‐1β promotes oligodendrocyte death through glutamate excitotoxicity
Takahashi, J. L., Giuliani, F., Power, C., Imai, Y., & Yong, V. W. (2003) · Annals of Neurology · doi:10.1002/ana.10519 · Cited by 256
Bates, K. A., Verdile, G., Li, Q.-X., Ames, D., Hudson, P., Masters, C. L., & Martins, R. N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.96 · Cited by 247
Human Stem Cell-Derived Spinal Cord Astrocytes with Defined Mature or Reactive Phenotypes
Roybon, L., Lamas, N. J., Garcia-Diaz, A., Yang, E. J., Sattler, R., Jackson-Lewis, V., Kim, Y. A., Kachel, C. A., Rothstein, J. D., Przedborski, S., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.06.021 · Cited by 208
Self-citationExcitatory Amino Acids and Multiple Sclerosis: Evidence From Cerebrospinal Fluid
Sarchielli, P., Greco, L., Floridi, A., Floridi, A., & Gallai, V. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1082 · Cited by 168
Clark, I. A., & Vissel, B. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0708-2 · Cited by 123
SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models
Kwon, O., Song, J., Yang, Y., Kim, S., Kim, J. Y., Seok, M., Hwang, I., Yu, J., Karmacharya, J., Maeng, H., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013076 · Cited by 110
Szymocha, R., Akaoka, H., Dutuit, M., Malcus, C., Didier-Bazes, M., Belin, M.-F., & Giraudon, P. (2000) · Journal of Virology · doi:10.1128/jvi.74.14.6433-6441.2000 · Cited by 83
MicroRNA expression patterns in human astrocytes in relation to anatomical location and age.
Rao, V. T. S., Ludwin, S. K., Fuh, S.-C., Sawaya, R., Moore, C. S., Ho, M.-K., Bedell, B. J., Sarnat, H. B., Bar-Or, A., & Antel, J. P. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlv016 · Cited by 50
Inhibition of glutamate transporter by theanine enhances the therapeutic efficacy of doxorubicin
Sugiyama, T., Sadzuka, Y., Tanaka, K., & Sonobe, T. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00317-4 · Cited by 47
Metadata
- Authors
- Fine, S. M., Angel, R. A., Perry, S. W., Epstein, L. G., Rothstein, J. D., Dewhurst, S., & Gelbard, H. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1996-06
- Volume
- 271
- Issue
- 26
- Pages
- 15303-15306
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2024285818
- Cited by
- 324
- References
- 29
- FWCI
- 11.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.